Melbourne Clinical Trials

The Mosquito Virus Study

This study is exploring a potential new study for Japanese Encephalitis Virus (JEV).

nights
2 vaccinations, 7 follow-up visits, 1 phone consultation. visits

The study is exploring and evaluating the safety, reactogenicity, and immunogenicity of a new potential vaccine for Japanese Encephalitis Virus (JEV), in healthy volunteers. Your participation can help pave the way for further clinical development and potential future use of the study vaccine.

The goal of the study vaccine is to protect people from Japanese Encephalitis and functions using mRNA (a type of genetic material acting as a messenger) to teach the body’s cells to make proteins from the virus. These proteins help the immune system recognize and fight the virus if the person encounters it later.

Join us in this journey as a healthy volunteer! Your participation could be key to advancing medical research and bringing new hope to patients worldwide.

Call us on 1300 553 604

Eligibility

Biological Sex Female or Male
BMI 19.5 - 28 kg/m²
Age 18 - 55 years old
Medical History No significant medical history
Smoking History Non-smokers and/ or have not smoked within 12 weeks prior to screening